PGY2 Clinical Pharmacogenomics
Pharmacy Residency
The PGY2 Clinical Pharmacogenomics Pharmacy Residency at St. Elizabeth Healthcare is an American Society of Health-System Pharmacists (ASHP) candidate for accreditation. The residency is a 12-month structured training program designed to cultivate competent and innovative practitioners who can use patient-specific pharmacogenomic (PGx) profiles to design safe and effective medication regimens across the continuum of care. The PGY2 Clinical Pharmacogenomics resident will develop expertise in genomics, clinical pharmacology, implementation science, informatics, and operational leadership, equipping them to catalyze the implementation of precision medicine in healthcare. The PGY2 residency is composed of five major elements:
Residency Program Leadership
PGY2 Clinical Pharmacogenomics Pharmacy
Residency Program Director
Josiah Allen, Pharm.D.
Josiah.Allen@stelizabeth.com
Program Structure
The structure of the residency program at St. Elizabeth Healthcare is based around multiple learning experiences (rotations). Staffing experiences will occur on the weekends with residency specific activities occurring Monday through Friday. The typical resident schedule is Monday through Friday and every third weekend.
Rotations
The St. Elizabeth Healthcare PGY2 Clinical Pharmacogenomics Pharmacy Residency offers a selection of diverse, specialized patient care rotations, allowing the resident to gain experience in multiple practice areas where pharmacogenomic information may be used. During each rotation, the resident is expected to perform independently and demonstrate an increasing proficiency in pharmacy practice. The resident will develop critical thinking skills while monitoring patient progress and medication therapy.
The St. Elizabeth Healthcare PGY2 Clinical Pharmacogenomics Pharmacy Residency offers the resident the opportunity to select one of three elective tracks. Each track is designed to provide the resident with a more intensive experience in the application of PGx in a particular practice area. Elective track options include Advanced PGx and Genomic Medicine, Ambulatory Care, and Oncology.
Required Rotations:
- Orientation
- Pharmacogenomics I
- Pharmacogenomics II
- Pediatrics
- Oncology
- Cardiology
- Primary Care I
- Medication Management Clinic I
- Research & Practice Advancement
Required Longitudinal Rotations:
- Pharmacogenomics Clinic
- Grand Rounds
- Pharmacy Staffing
- Research and Practice Advancement
-
- Clinical Research Project
- Economic Evaluation Project
- Implementation Science Project
Elective Tracks:
Elective Tracks:
- Advanced PGx and Genomic Medicine
- Pharmacogenomics III
- Pharmacogenomics Laboratory
- Pharmacogenomics Informatics
- Genomic Medicine
- Academia (longitudinal)
- Ambulatory Care (longitudinal, 1 day per week each)
- Population Health
- Primary Care II
- Medication Management Clinic II
- Family Practice Center
- Oncology
- Oncology Infusion
- Oncology Clinic
- Inpatient Oncology
- Molecular Tumor Board (longitudinal)
Clinical Research Project
Completion of a clinical research project is a required component of the residency programs. The purpose of this requirement is to introduce the resident to the principles of scientific method including the design, preparation, performance and interpretation of a medical project. The resident also gains experience in the preparation of a manuscript for publication and improves his/her public speaking skills through formal presentation.
Economic Evaluation Project
The PGY2 Clinical Pharmacogenomics Pharmacy Resident will conduct Economic Evaluation project during their residency year. The resident will perform a financial analysis or cost-effectiveness evaluation designed to evaluate health economics associated with implementation of precision medicine. The purpose of this requirement is to fully incorporate the Institute for Healthcare Improvement (IHI) Triple Aim into PGx practice, hone operational leadership skills, and improve presentation skills.
Implementation Science Project
The PGY2 Clinical Pharmacogenomics Pharmacy Resident will conduct one implementation project during their residency year. The specifics of the implementation project will vary but examples include implementation of PGx testing in a new practice area or service line, evaluation and optimization of electronic clinical decision support tools, development of educational tools to support clinical implementation, assessment of patient and provider perspectives on PGx, etc. The purpose of this requirement is to introduce the resident to the discipline of implementation science and apply this skillset in practice.
Hospital Committee Assignment
The PGY2 Clinical Pharmacogenomics Pharmacy Resident is required to serve on the Pharmacogenomics Advisory Committee as a non-voting member. The purpose of this activity is to provide the resident with the opportunity to gain experience in the decision-making process encountered with committee work as well as multi-disciplinary interactions in a setting outside of clinical practice.
Teaching Certificate Program
Though not a program requirement, residents have the opportunity to participate in the Teaching Certificate Program (TCP) affiliated with the James L. Winkle College of Pharmacy (University of Cincinnati). Residents participate in formal seminars on precepting philosophy and technique, teaching experiences at the college of pharmacy, and the development of a teaching portfolio program. This program will allow the resident to gain a broad understanding of issues in pharmacy education and opportunities to practice their teaching skills.
